News items related to:
-
IN PHOTOS: Make Medicines Affordable – for all
Millions of people die unnecessarily each year because life-saving medicines are overpriced. Tactics often employed by pharmaceutical companies keep prices...
-
Activists ask pharma corporations: “Is the Middle East and North Africa a priority?”
A CAB meeting was held in Morocco, providing an opportunity to discuss access to treatment in a region facing an...
-
We can’t end AIDS without tackling patent abuse
Despite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...
-
TEDWomen: Why are drug prices so high?
Hear from I-MAK’s Priti Krishtel on how the outdated patent system is the hidden reason that drug prices are so high...
-
“If a pharma exec saw my baby die they’d still overprice their drugs” – Noi, Thailand
Written by Gemma Taylor. Noi, 48, is a regional coordinator for the Issan region of Thailand, with the Thai national...
-
ITPC’s Global Survey on Access to and Quality of HIV Treatment and Care
ITPC’s Global Survey on Access to and Quality of HIV Treatment and Care focused on barriers to quality HIV care...
-
World CAB: Direct dialogue between pharma companies and HIV, Hep C and TB treatment advocates
This Autumn, for the first time in over 10 years, a World Community Advisory Board (CAB) which included a focus...
-
Love, life and riots. Fighting for rights in Georgia
Access to optimal treatment for HIV, Hepatitis C and all essential medicines should be equitable. Unnecessary barriers are standing in...
-
ITPC backs fight against replacement of HIV drug dolutegravir in El Salvador
For more than a month, people living with HIV in El Salvador’s capital city have been surviving a shortage of...
-
Activists fear looming health crisis in Argentina – call on IMF to act
Today global health activists took to the streets in Washington DC to highlight the looming health crisis facing the people...
-
The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system
Today’s drug patent monopolies are stronger than at any point in the last century, raising prescription prices, reports Tahir Amin...
-
Argentina: GEP filed new opposition to patent request for Hepatitis C drug
A significant step in ensuring access to treatment for the 800,000 people living with hepatitis C in Argentina. Earlier this...
